Antigen Information
General Information of This Antigen
| Antigen ID | TAR0QHAVI |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Folate receptor alpha (FOLR1) |
|||||
| Gene Name | FOLR1 |
|||||
| Gene ID | ||||||
| Synonym | FOLR; Adult folate-binding protein;Folate receptor 1;Folate receptor, adult;KB cells FBP;Ovarian tumor-associated antigen MOv18 |
|||||
| Sequence |
MAQRMTTQLLLLLVWVAVVGEAQTRIAWARTELLNVCMNAKHHKEKPGPEDKLHEQCRPW
RKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQV DQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHF YFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMSGAGPWA AWPFLLSLALMLLWLLS Click to Show/Hide
|
|||||
| Family | Ephrin family |
|||||
| Function |
Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release. Required for normal embryonic development and normal cell proliferation.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Ab-151
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AMT-151 |
Duostatin 5 |
Microtubule (MT) |
Pip-Val-Cit linker |
AB1380026
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380026-SG3932 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
AB1380035
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380035-SG3932 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
AB1380049
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380049-SG3932 (DAR8) |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] | |
AB1380049-SG3932 (DAR4) |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
AB1380083
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380083-SG3932 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
AB1380095
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380095-SG3932 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
AB1380117
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AB1380117-SG3932 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
[1] |
Anti-FOLR1 huFR1-48
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-48-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] |
Anti-FOLR1 huFR1-49
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-49-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] |
Anti-FOLR1 huFR1-57
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-57-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] |
Anti-FOLR1 huFR1-65
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-65-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] |
Anti-FOLR1 IgG1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ZW191 |
ZD06519 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly-AM |
Anti-FOLR1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-FOLR1-Ala-Ala-IGN |
Indolinobenzodiazepine dimer |
Human Deoxyribonucleic acid (hDNA) |
Ala-Ala dipeptide |
[3] | |
Anti-FOLR1-Val-Gln-IGN |
Indolinobenzodiazepine dimer |
Human Deoxyribonucleic acid (hDNA) |
Val-Gln dipeptide linker |
[3] | |
FOLR1-ADC 13a |
PBD dimer 13a |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
[4] | |
FOLR1-ADC 13b |
PBD dimer 13b |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
[4] | |
FOLR1-ADC 13c |
PBD dimer 13c |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
[4] | |
FOLR1-ADC 15 |
PBD dimer 13c |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-CIt-PABC |
[4] |
Anti-FRα antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
BAT8006 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
||
GenSci140 |
GSC5181 |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-FRα mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SYS6041 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
[5] |
B10 F404
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN114269749B anti-FolR1 ADC2 |
CN114269749B anti-FolR1 ADC1 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
[6] |
F131
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
F131-LD038 |
F131-LD038 payload |
Undisclosed |
F131-LD038 linker |
[7] | |
F131-LD100 |
F131-LD100 payload |
Undisclosed |
F131-LD100 linker |
[7] | |
F131-LD111 |
F131-LD111 payload |
Undisclosed |
F131-LD111 linker |
[7] | |
F131-LD101 |
F131-LD101 payload |
Undisclosed |
F131-LD101 linker |
[7] | |
F131-LD110 |
F131-LD110 payload |
Undisclosed |
F131-LD110 linker |
[7] |
Farletuzumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Farletuzumab ecteribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2-Val-Cit-PABC |
||
Farletuzumab-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
Farletuzumab-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
Farletuzumab-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
Farletuzumab-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
Farletuzumab-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
Farletuzumab-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
Farletuzumab-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
Farletuzumab-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FOLR1-Mal-PEG2-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2-Val-Cit-PABC |
[9] | |
FOLR1-Mal-PEG8-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG8-Val-Cit-PABC |
[9] | |
FOLR1-Mal-Caproyl-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[9] | |
FOLR1-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2-Ala-Ala-Asn-PABC |
[9] | |
FOLR1-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC |
[9] | |
FOLR1-Mal-PEG4-tria-PEG3-Sulfo-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Sulfonamide |
[9] | |
FOLR1-Mal-PEG2-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG2 |
[9] | |
FOLR1-Mal-PEG4-Eribulin |
Eribulin |
Microtubule (MT) |
Mal-PEG4 |
[9] | |
FOLR1-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4-Val-Cit-PABC |
[9] | |
FOLR1-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC |
[9] | |
FOLR1-Suc/SPAAC-PEG3-Sulfonamide-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Sulfonamide |
[9] | |
FOLR1-Suc/SPAAC-PEG2-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG2 |
[9] | |
FOLR1-Suc/SPAAC-PEG4-Eribulin |
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4 |
[9] | |
FOLR1-Mal-PEG-Val-Cit-PABC-Cryptophycin |
Cryptophycin |
Microtubule (MT) |
Mal-PEG-Val-Cit-PABC |
[9] | |
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[9] | |
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
[9] | |
Farletuzumab-sulfo SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[9] | |
CN119630431A ADC-6 |
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
Undisclosed |
[10] | |
CN119630431A ADC-7 |
CN119630431A ADC-51 payload |
Undisclosed |
Undisclosed |
[10] | |
CN119630431A ADC-8 |
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
CN119630431A-ADC-5-LINKER |
[10] |
Fc-silent FRalpha specific humanized IgG1 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LY-4170156 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
Mal-Polysarcosine10-Val-Ala-PABC |
FR-alpha antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN115429893A ADC16 |
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
[11] |
FR1-21
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
FR1-21-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FR1-21-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
FR1-21-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
FR1-21-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
FR1-21-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
FR1-21-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
FR1-21-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
FR1-21-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
FR1-48
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
FR1-48-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FR1-48-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
FR1-48-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
FR1-48-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
FR1-48-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
FR1-48-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
FR1-48-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
FR1-48-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
FR1-49
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
FR1-49-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FR1-49-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
FR1-49-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
FR1-49-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
FR1-49-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
FR1-49-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
FR1-49-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
FR1-49-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
FR1-57
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
FR1-57-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FR1-57-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
FR1-57-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
FR1-57-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
FR1-57-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
FR1-57-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
FR1-57-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
FR1-57-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
FR1-65
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
FR1-65-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
FR1-65-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
FR1-65-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
FR1-65-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
FR1-65-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
FR1-65-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
FR1-65-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
FR1-65-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
H01 Y180F404
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN114269749B anti-FolR1 ADC1 |
CN114269749B anti-FolR1 ADC1 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
[6] | |
CN114269749B anti-FolR1 ADC3 |
CN114269749B anti-FolR1 ADC3 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
[6] |
huFR1-21
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-21-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuFR1-21-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
HuFR1-21-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
HuFR1-21-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
HuFR1-21-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
HuFR1-21-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
HuFR1-21-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuFR1-21-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
huFR1-23
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuFR1-23-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuFR1-23-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
HuFR1-23-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
HuFR1-23-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
HuFR1-23-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
HuFR1-23-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
HuFR1-23-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuFR1-23-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
huMov19
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMov19-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuMov19-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
HuMov19-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
HuMov19-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
HuMov19-sulfo-SPDB-DM4 (DAR3.8) |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
HuMov19-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
HuMov19-3-sulfo-Mal-DM4 (DAR 3.7) |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuMov19-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuMov19-3-sulfo-Mal-DM4 (DAR 8.23) |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuMov19-sulfo-SPDB-DM4 (DAR6.8) |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] |
huMOV19v1.0
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMOV19v1.0-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuMOV19v1.0-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
HuMOV19v1.0-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
HuMOV19v1.0-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
HuMOV19v1.0-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
HuMOV19v1.0-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
HuMOV19v1.0-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuMOV19v1.0-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
huMOV19v1.6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMOV19v1.6-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
HuMOV19v1.6-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
HuMOV19v1.6-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
HuMOV19v1.6-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
HuMOV19v1.6-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
HuMOV19v1.6-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
HuMOV19v1.6-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
HuMOV19v1.6-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
Isumab01
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IKS-01 |
FGX2-62 |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
[12] |
Luveltamab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Luveltamab tazevibulin |
SC209 |
Microtubule (MT) |
DBCO-Val-Cit-PABA |
Mirvetuximab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Mirvetuximab soravtansine |
DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[13] | |
Mirvetuximab-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[2] | |
Mirvetuximab-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[14] | |
Mirvetuximab-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] | |
M9346A Sulfo-SPDB DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[2] | |
M9346A-CX-DM1 |
Mertansine DM1 |
Microtubule (MT) |
triglycyl peptide linker CX |
[15] | |
M9346A-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
M9346A-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
M9346A-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
M9346A-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
37307297 ADC 10 |
FD-1 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 11 |
FD-1 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 21 |
FD-1 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 22 |
FD-1 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 23 |
FD-1 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 24 |
FD-2 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 25 |
FD-2 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 26 |
FD-3 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 27 |
FD-3 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 28 |
FD-9 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 29 |
FD-9 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 30 |
FD-22 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 31 |
FD-11 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 32 |
FD-23 |
Undisclosed |
Undisclosed |
[16] | |
37307297 ADC 33 |
FD-19 |
Undisclosed |
Undisclosed |
[16] |
mirvetuximab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IGAC-91 |
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
[17] |
Mirvetuximab (engineered cysteine HC-C118)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
M9346A-4c-Cxxx-Mal-CX-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
[15] |
Mirvetuximab (engineered cysteine HC-C239)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
M9346A-4d-Cxxx-Mal-CX-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
[15] |
Mirvetuximab (engineered cysteine LC-C205)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
M9346A-4a-Cxxx-Mal-CX-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
[15] |
Mirvetuximab (engineered cysteine LC-C400)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
M9346A-4b-Cxxx-Mal-CX-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
[15] |
Morab-003
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
39424599 ADC-10A |
Undisclosed |
Undisclosed |
Electron-deficient sulfonamide-based cleavable linker 10 |
[18] | |
39424599 ADC-S32A |
Undisclosed |
Undisclosed |
Electron-deficient Disulfide-based cleavable linker 32 |
[18] |
MORAb-003
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MORAb-003 ADC1 |
Nostocyclopeptide-1 |
Undisclosed |
Maleimidyl - PEG3 - benzyl - disulfide - dimethyl linker |
[19] | |
MORAb-003 ADC2 |
Nostocyclopeptide-2 |
Undisclosed |
LL2 linker |
[19] | |
MORAb-003 ADC3 |
Nostocyclopeptide-2 |
Undisclosed |
LL3 linker |
[19] | |
MORAb-003 ADC4 |
Nostocyclopeptide-2 |
Undisclosed |
VCP linker |
[19] | |
MORAb-003 ADC5 |
Eribulin |
Microtubule (MT) |
VCP linker |
[19] | |
MORAb-003 ADC6 |
ER-001150828 |
Undisclosed |
Maleimidyl- (CH2)5-Val-Cit-pAB linker |
[19] | |
MORAb-003 ADC7 |
ER-001150828 |
Undisclosed |
Maleimidyl-PEG2-Val-Cit-pAB linker |
[19] | |
MORAb-003 ADC8 |
Mertansine DM1 |
Microtubule (MT) |
6-Maleimidocaproic acid |
[19] | |
MORAb-003 ADC9 |
Monomethyl auristatin E |
Microtubule (MT) |
Maleimidyl- (CH2)5-Val-Cit-pAB linker |
[19] | |
MORAb-003 ADC10 |
Auristatin F |
Microtubule (MT) |
NHS-PEG2 linker |
[19] | |
MORAb-003 ADC11 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[19] | |
MORAb-003 ADC12 |
Dolicatatin 3 |
Undisclosed |
PEG-pAB linker |
[19] | |
MORAb-003 ADC13 |
Dolicatatin 5 |
Microtubule (MT) |
Asn-Ala linker |
[19] | |
MORAb-003 ADC14 |
Dolicatatin 3 |
Undisclosed |
Undisclosed |
[19] | |
MORAb-003 ADC15 |
Dolicatatin 10 |
Undisclosed |
PEG-pAB linker |
[19] | |
MORAb-003 ADC16 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[19] | |
MORAb-003 ADC17 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[19] | |
MORAb-003 ADC18 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC19 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC20 |
Polymycin 7 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC21 |
Polymycin 7 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC22 |
Polymycin 7 |
Undisclosed |
PEG-pAB linker |
[20] | |
MORAb-003 ADC23 |
Polymycin 7 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC24 |
Dolicatatin 7 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC25 |
Dolicatatin 6 |
Undisclosed |
PEG-pAB linker |
[20] | |
MORAb-003 ADC26 |
Dolicatatin 10 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC27 |
Dolicatatin 10 |
Undisclosed |
PEG-pAB linker |
[20] | |
MORAb-003 ADC28 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC29 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC30 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC31 |
Dolicatatin 14 |
Undisclosed |
PEG-pAB linker |
[20] | |
MORAb-003 ADC32 |
Dolicatatin 14 |
Undisclosed |
Undisclosed |
[20] | |
MORAb-003 ADC33 |
Dolicatatin 5 |
Microtubule (MT) |
PEG-pAB linker |
[20] |
Mov19
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Mov19-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
Mov19-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
Mov19-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
Mov19-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
Mov19-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
Mov19-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
Mov19-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
Mov19-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
mu-FR1-13
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MuFR1-13-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
MuFR1-13-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
MuFR1-13-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
MuFR1-13-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
MuFR1-13-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
MuFR1-13-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
MuFR1-13-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
MuFR1-13-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
mu-FR1-21
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MuFR1-21-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
MuFR1-21-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
MuFR1-21-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
MuFR1-21-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
MuFR1-21-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
MuFR1-21-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
MuFR1-21-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
MuFR1-21-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
mu-FR1-22
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MuFR1-22-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
MuFR1-22-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
MuFR1-22-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
MuFR1-22-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
MuFR1-22-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
MuFR1-22-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
MuFR1-22-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
MuFR1-22-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
mu-FR1-23
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MuFR1-23-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
MuFR1-23-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
MuFR1-23-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
MuFR1-23-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
MuFR1-23-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
MuFR1-23-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
MuFR1-23-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
MuFR1-23-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
mu-FR1-9
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MuFR1-9-PEG4-Mal-DM1 |
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
[8] | |
MuFR1-9-SMCC-DM1 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[8] | |
MuFR1-9-SIA-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
[8] | |
MuFR1-9-SPP-DM1 |
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[8] | |
MuFR1-9-sulfo-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
[8] | |
MuFR1-9-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[8] | |
MuFR1-9-3-sulfo-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
[8] | |
MuFR1-9-PEG4-Mal-DM4 |
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
[8] |
Opugotamig
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Opugotamig olatansine |
DM21-C |
Microtubule (MT) |
Stable cleavable peptide linker |
Rinatabart
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Rinatabart sesutecan |
Exatecan |
DNA topoisomerase 1 (TOP1) |
T1000 |
SIBP-A12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SIBP-A19 |
DXd |
DNA topoisomerase 1 (TOP1) |
Mc-VASGFG |
Sofetabart
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
sofetabart mipitecan |
Exatecan |
DNA topoisomerase 1 (TOP1) |
Mal-Polysarcosine10-Val-Ala-PABC |
Torvutatug
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Torvutatug samrotecan |
AZ14170132 (AZ0132) |
DNA topoisomerase 1 (TOP1) |
Mal-PEG8-Val-Ala |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuIgG1-SPDB-DM4 |
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
[2] | |
Anti-FolRa Iadc |
Undisclosed |
Undisclosed |
Undisclosed |
[21] | |
FOLR1 maytansinoid based antibody-drug conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
M-DGN549 |
Undisclosed |
Undisclosed |
Undisclosed |
[23] | |
DNA-alkylating anti-FRalpha antibody-drug conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[24] | |
IKS-012 |
Undisclosed |
Undisclosed |
Undisclosed |
[25] | |
ALT-Q5 |
Undisclosed |
Undisclosed |
Undisclosed |
[26] | |
BB-17 |
Undisclosed |
Undisclosed |
Undisclosed |
[27] | |
Isumab01-C1a |
Undisclosed |
Undisclosed |
Undisclosed |
[29] | |
Isumab01-C1b |
Undisclosed |
Undisclosed |
Undisclosed |
[29] | |
Isumab01-C2a |
WO2025015586A1, ADC25, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] | |
Isumab01-C2b |
WO2025015586A1, ADC25, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] | |
Isumab01-C3 |
WO2025015586A1, ADC23, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] | |
Isumab01-C4 |
compound 4 |
DNA topoisomerase I (TOP1) |
Undisclosed |
[29] | |
Isumab01-C5 |
compound 5 |
DNA topoisomerase I (TOP1) |
Undisclosed |
[29] | |
Isumab01-C6 |
WO2025015586A1, ADC24, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] | |
Isumab01-C7 |
WO2025015586A1, ADC34, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] | |
Isumab01-C8 |
WO2025015586A1, ADC35, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[29] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
39424599 ADC-S35A |
Undisclosed |
Undisclosed |
S35 linker |
[18] | |
CN115429893A ADC17 |
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
[11] | |
anti-FOLR1-151-K-LOCK-D5 |
AU2023267043A1 ADC-5 Payload |
Undisclosed |
AU2023267043A1 ADC-5 Linker |
[28] | |
anti-FOLR1-151-C-LOCK-D5 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] |
References
